Improvements in Hemoglobin and Cognitive Function from Opera: A Real-World Study of Pegcetacoplan Treatment in US Adults with Paroxysmal Nocturnal Hemoglobinuria

被引：1
|
作者：
Fishman, Jesse [1 ]
Min, Jinny [1 ]
Arnett, Lily [2 ]
Shenoy, Apeksha [2 ]
机构：
[1] Apellis Pharmaceut, Waltham, MA USA
[2] Boston Strateg Partners Inc, Boston, MA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-189167
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Real-World Eculizumab Dosing Patterns Among Patients with Paroxysmal Nocturnal Hemoglobinuria in a US Population
    Cheng, Wendy Y.
    Sarda, Sujata P.
    Mody-Patel, Nikita
    Krishnan, Sangeeta
    Yenikomshian, Mihran
    Kunzweiler, Colin
    Vu, Jensen Duy
    Cheung, Hoi Ching
    Duh, Mei Sheng
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2022, 14 : 357 - 369
  • [22] Real-World Clinical Outcomes for Complement Inhibitor Experienced and Naive Paroxysmal Nocturnal Hemoglobinuria Patients Prescribed Pegcetacoplan in Europe and Canada
    Panse, Jens
    Llamas, Juan Carlos Vallejo
    Wilson, Koo
    Hakimi, Zalmai
    Czech, Barbara
    Kerr, Brianne
    Williamson, Sam
    Garratt-Wheeldon, Jade
    Taylor, Yasmin
    Hatchell, Niall
    Patriquin, Christopher
    BLOOD, 2024, 144 : 5085 - 5086
  • [23] Real-World Characteristics and Treatment History of Patients with Paroxysmal Nocturnal Hemoglobinuria Initiating Iptacopan in US Administrative Claims Data
    Shammo, Jamile
    Bilano, Ver
    Noshad, Sina
    Geevarghese, Lincy
    Yen, Glorian
    Paulose, Jincy
    Sorg, Rachael
    Boyd, Marley
    Keshishian, Allison
    Kim, Sonia
    Tomicki, Samantha
    Lee, Soyon
    BLOOD, 2024, 144 : 5681 - 5682
  • [24] Real-World Treatment Outcomes of Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated with Pegcetacoplan and Complement Protein 5 Inhibitors (C5i)
    Majerus, Elaine M.
    Mulherin, Brian
    Wilson, Koo
    Fishman, Jesse
    Mellor, Jennifer
    Earl, Lucy
    Roeth, Alexander
    BLOOD, 2023, 142
  • [25] Pegcetacoplan: the first and only C3-targeted therapy for the treatment of adults with paroxysmal nocturnal hemoglobinuria
    Chan, Tze Wei
    Than, Hein
    Tuy, Tertius
    Goh, Yeow Tee
    EXPERT REVIEW OF HEMATOLOGY, 2025, 18 (01) : 11 - 20
  • [26] The cost-effectiveness of pegcetacoplan in complement treatment-naive adults with paroxysmal nocturnal hemoglobinuria in the USA
    Fishman, Jesse
    Wilson, Koo
    Drzewiecka, Aleksandra
    Pochopien, Michal
    Dingli, David
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2023, 12 (10)
  • [27] A REAL-WORLD ANALYSIS OF TREATMENT ADHERENCE AND CLINICAL OUTCOMES FOR PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA (PNH) RECEIVING PEGCETACOPLAN
    Wilson, Koo
    Rich, Carly
    Hakimi, Zalmai
    Horneff, Regina
    Fishman, Jesse
    Mellor, Jennifer
    Earl, Lucy
    Taylor, Yasmin
    Simons, Alice
    BONE MARROW TRANSPLANTATION, 2024, 59 : 190 - 191
  • [28] Real-World Efficacy of Eculizumab for Paroxysmal Nocturnal Hemoglobinuria in South Korea: Paradox of Eculizumab
    Kang, Ka-Won
    Moon, Hyemi
    Lee, Byung-Hyun
    Jeon, Min Ji
    Yu, Eun Sang
    Kim, Dae Sik
    Lee, Se Ryeon
    Sung, Hwa Jung
    Kim, Seok Jin
    Choi, Chul Won
    Kim, Byung Soo
    Lee, Juneyoung
    Park, Yong
    BLOOD, 2019, 134
  • [29] Iptacopan Treatment Improves Clinical Parameters in a Real-World Cohort with Paroxysmal Nocturnal Hemoglobinuria: Evidence from a Managed Access Program
    Snellman, Josefin
    Tiwari, Ranjan
    Khan, Abdulfaheem
    Rizk, Sviatlana
    Pilipovic, Virginia
    BLOOD, 2024, 144 : 5692 - 5693
  • [30] Real-World Treatment Patterns and Healthcare Resource Utilization (HRU) of Patients (Pts) with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Eculizumab in a US Population
    Cheng, Wendy Y.
    Sarda, Sujata P.
    Mody-Patel, Nikita
    Krishnan, Sangeeta
    Yenikomshian, Mihran
    Scoble, Patrick J.
    Mahendran, Malena
    Lejeune, Dominique
    Yu, Louise
    Duh, Mei Sheng
    BLOOD, 2020, 136
12345